<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37750203</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2052-1707</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Pharmacology research &amp; perspectives</Title><ISOAbbreviation>Pharmacol Res Perspect</ISOAbbreviation></Journal><ArticleTitle>Autocrine positive feedback of tumor necrosis factor from activated microglia proposed to be of widespread relevance in chronic neurological disease.</ArticleTitle><Pagination><StartPage>e01136</StartPage><MedlinePgn>e01136</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01136</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/prp2.1136</ELocationID><Abstract><AbstractText>Over a decade's experience of post-stroke rehabilitation by administering the specific anti-TNF biological, etanercept, by the novel perispinal route, is consistent with a wide range of chronically diminished neurological function having been caused by persistent excessive cerebral levels of TNF. We propose that this TNF persistence, and cerebral disease chronicity, largely arises from a positive autocrine feedback loop of this cytokine, allowing the persistence of microglial activation caused by the excess TNF that these cells produce. It appears that many of these observations have never been exploited to construct a broad understanding and treatment of certain chronic, yet reversible, neurological illnesses. We propose that this treatment allows these chronically activated microglia to revert to their normal quiescent state, rather than simply neutralizing the direct harmful effects of this cytokine after its release from microglia. Logically, this also applies to the chronic cerebral aspects of various other neurological conditions characterized by activated microglia. These include long COVID, Lyme disease, post-stroke syndromes, traumatic brain injury, chronic traumatic encephalopathy, post-chemotherapy, post-irradiation cerebral dysfunction, cerebral palsy, fetal alcohol syndrome, hepatic encephalopathy, the antinociceptive state of morphine tolerance, and neurogenic pain. In addition, certain psychiatric states, in isolation or as sequelae of infectious diseases such as Lyme disease and long COVID, are candidates for being understood through this approach and treated accordingly. Perispinal etanercept provides the prospect of being able to treat various chronic central nervous system illnesses, whether they are of infectious or non-infectious origin, through reversing excess TNF generation by microglia.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Pharmacology Research &amp; Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Ian A</ForeName><Initials>IA</Initials><Identifier Source="ORCID">0000-0003-1945-0370</Identifier><AffiliationInfo><Affiliation>Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vissel</LastName><ForeName>Bryce</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-8860-8050</Identifier><AffiliationInfo><Affiliation>St Vincent's Hospital Centre for Applied Medical Research, St Vincent's Hospital, Darlinghurst, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UNSW Medicine &amp; Health, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pharmacol Res Perspect</MedlineTA><NlmUniqueID>101626369</NlmUniqueID><ISSNLinking>2052-1707</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>OP401G7OJC</RegistryNumber><NameOfSubstance UI="D000068800">Etanercept</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000079424">Tumor Necrosis Factor Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068800" MajorTopicYN="N">Etanercept</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079424" MajorTopicYN="N">Tumor Necrosis Factor Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="Y">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025461" MajorTopicYN="N">Feedback, Physiological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TNF</Keyword><Keyword MajorTopicYN="N">activated microglia</Keyword><Keyword MajorTopicYN="N">autocrine feedback loop</Keyword><Keyword MajorTopicYN="N">endometriosis pain</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-stroke</Keyword><Keyword MajorTopicYN="N">psychiatric states</Keyword></KeywordList><CoiStatement>Neither author has any conflict of interest regarding the contents of this manuscript. Because of the commentary nature of this article, no novel data is available, nor patient or animal ethics involved.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37750203</ArticleId><ArticleId IdType="pmc">PMC10520644</ArticleId><ArticleId IdType="doi">10.1002/prp2.1136</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Qin LY, Wu XF, Block ML, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453&#x2010;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2871685</ArticleId><ArticleId IdType="pubmed">17203472</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuno R, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. Autocrine activation of microglia by tumor necrosis factor&#x2010;alpha. J Neuroimmunol. 2005;162(1&#x2013;2):89&#x2010;96. doi:10.1016/j.jneuroim.2005.01.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2005.01.015</ArticleId><ArticleId IdType="pubmed">15833363</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinshamn S, Waage A. Lack of endotoxin tolerance with respect to TNF alpha production in the subarachnoid space. APMIS. 2000;108(2):107&#x2010;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">10737455</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Zhang D, Tao T, et al. The role of N&#x2010;glycan modification of TNFR1 in inflammatory microglia activation. Glycoconj J. 2015;32(9):685&#x2010;693. doi:10.1007/s10719-015-9619-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10719-015-9619-1</ArticleId><ArticleId IdType="pubmed">26452604</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick EL. Perispinal delivery of CNS drugs. CNS Drugs. 2016;30:469&#x2010;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4920856</ArticleId><ArticleId IdType="pubmed">27120182</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick E. Perispinal etanercept: a new therapeutic paradigm in neurology. Expert Rev Neurother. 2010;10(6):985&#x2010;1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">20518613</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark IA, Alleva LM, Vissel B. The roles of TNF in brain dysfunction and disease. Pharmacol Ther. 2010;128:519&#x2010;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">20813131</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris GP, Clark IA, Zinn R, Vissel B. Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research. Neurobiol Learn Mem. 2013;105:40&#x2010;53. doi:10.1016/j.nlm.2013.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nlm.2013.07.002</ArticleId><ArticleId IdType="pubmed">23850597</ArticleId></ArticleIdList></Reference><Reference><Citation>Block ML, Zecca L, Hong JS. Microglia&#x2010;mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57&#x2010;69. doi:10.1038/nrn2038</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2038</ArticleId><ArticleId IdType="pubmed">17180163</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitelaw BS, Stoessel MB, Majewska AK. Movers and shakers: microglial dynamics and modulation of neural networks. Glia. 2022;71:1575&#x2010;1591. doi:10.1002/glia.24323</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24323</ArticleId><ArticleId IdType="pmc">PMC10729610</ArticleId><ArticleId IdType="pubmed">36533844</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark IA, Vissel B. Amyloid beta: one of three danger&#x2010;associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease. Br J Pharmacol. 2015;172(15):3714&#x2010;3727. doi:10.1111/bph.13181</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13181</ArticleId><ArticleId IdType="pmc">PMC4523330</ArticleId><ArticleId IdType="pubmed">25939581</ArticleId></ArticleIdList></Reference><Reference><Citation>Janeway CA. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today. 1992;13(1):111&#x2010;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">1739426</ArticleId></ArticleIdList></Reference><Reference><Citation>Matzinger P. The danger model: a renewed sense of self. Science. 2002;296(5566):301&#x2010;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">11951032</ArticleId></ArticleIdList></Reference><Reference><Citation>Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg. 1940;112(1):138&#x2010;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1387927</ArticleId><ArticleId IdType="pubmed">17857618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen TS, Randall DC, Zolman JF. Protein accumulation in cerebrospinal fluid during &#x2212;90 degrees head&#x2010;down tilt in rabbit. J Appl Physiol. 1994;77(3):1081&#x2010;1086.</Citation><ArticleIdList><ArticleId IdType="pubmed">7836107</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick E. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. CNS Drugs. 2011;25(2):145&#x2010;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">21254790</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick E, Kim NM, Reyzin G, Rodriguez&#x2010;Romanacce H, DePuy V. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 2012;26(12):1051&#x2010;1070. doi:10.1007/s40263-012-0013-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-012-0013-2</ArticleId><ArticleId IdType="pubmed">23100196</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick E, Rodriguez&#x2010;Romanacce H, Levine A, Ignatowski TA, Spengler RN. Immediate neurological recovery following perispinal etanercept years after brain injury. Clin Drug Investig. 2014;34(5):361&#x2010;366. doi:10.1007/s40261-014-0186-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40261-014-0186-1</ArticleId><ArticleId IdType="pubmed">24647830</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick E. Immediate resolution of Hemispatial neglect and central post&#x2010;stroke pain after Perispinal Etanercept: case report. Clin Drug Investig. 2020;40(1):93&#x2010;97. doi:10.1007/s40261-019-00864-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40261-019-00864-8</ArticleId><ArticleId IdType="pmc">PMC6962280</ArticleId><ArticleId IdType="pubmed">31642048</ArticleId></ArticleIdList></Reference><Reference><Citation>Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun. 2011;25(2):181&#x2010;213. doi:10.1016/j.bbi.2010.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.10.015</ArticleId><ArticleId IdType="pubmed">20970492</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchessalova D, Posillico CK, Tronson NC. Neuroimmune activation drives multiple brain states. Front Syst Neurosci. 2018;12:39. doi:10.3389/fnsys.2018.00039</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2018.00039</ArticleId><ArticleId IdType="pmc">PMC6123349</ArticleId><ArticleId IdType="pubmed">30210310</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin I, Kipnis J. Learning and memory &#x2026; and the immune system. Learn Mem. 2013;20(10):601&#x2010;606. doi:10.1101/lm.028357.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/lm.028357.112</ArticleId><ArticleId IdType="pmc">PMC3768198</ArticleId><ArticleId IdType="pubmed">24051097</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering M, Cumiskey D, O'Connor JJ. Actions of TNF&#x2010;alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol. 2005;90(5):663&#x2010;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">15944202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson AR, Christensen RN, Gensel JC, et al. Cell death after spinal cord injury is exacerbated by rapid TNFalpha&#x2010;induced trafficking of GluR2&#x2010;lacking AMPARs to the plasma membrane. J Neurosci. 2008;28(44):11391&#x2010;11400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2598739</ArticleId><ArticleId IdType="pubmed">18971481</ArticleId></ArticleIdList></Reference><Reference><Citation>Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF&#x2010;alpha. Nature. 2006;440(7087):1054&#x2010;1059.</Citation><ArticleIdList><ArticleId IdType="pubmed">16547515</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark IA, Vissel B. Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti&#x2010;TNF agents. J Neuroinflammation. 2016;13(1):236. doi:10.1186/s12974-016-0708-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0708-2</ArticleId><ArticleId IdType="pmc">PMC5011997</ArticleId><ArticleId IdType="pubmed">27596607</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumiskey D, Butler MP, Moynagh PN, O'Connor JJ. Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor&#x2010;alpha on long&#x2010;term potentiation. Brain Res. 2007;1136(1):13&#x2010;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">17198691</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang L, Knox AJ. Regulation of TNF&#x2010;alpha&#x2010;induced eotaxin release from cultured human airway smooth muscle cells by beta2&#x2010;agonists and corticosteroids. FASEB J. 2001;15(1):261&#x2010;269. doi:10.1096/fj.00-0103com</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.00-0103com</ArticleId><ArticleId IdType="pubmed">11149914</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KM, Yule DI, Bowers WJ. Tumor necrosis factor&#x2010;alpha potentiates intraneuronal Ca2+ signaling via regulation of the inositol 1,4,5&#x2010;trisphosphate receptor. J Biol Chem. 2008;283(48):33069&#x2010;33079. doi:10.1074/jbc.M802209200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M802209200</ArticleId><ArticleId IdType="pmc">PMC2586262</ArticleId><ArticleId IdType="pubmed">18838384</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardino L, Agasse F, Silva B, Ferreira R, Grade S, Malva JO. Tumor necrosis factor&#x2010;alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells. 2008;26(9):2361&#x2010;2371.</Citation><ArticleIdList><ArticleId IdType="pubmed">18583543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez&#x2010;Alcazar JA, Schneider E, Martinez MA, et al. Tumor necrosis factor&#x2010;alpha increases the steady&#x2010;state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem. 2000;275(18):13353&#x2010;13361.</Citation><ArticleIdList><ArticleId IdType="pubmed">10788444</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan S, Cai GQ, Zheng A, et al. Tumor necrosis factor&#x2010;alpha regulates the hypocretin system via mRNA degradation and ubiquitination. Biochim Biophys Acta. 2011;1812(4):565&#x2010;571. doi:10.1016/j.bbadis.2010.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2010.11.003</ArticleId><ArticleId IdType="pmc">PMC3042489</ArticleId><ArticleId IdType="pubmed">21094253</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark IA, Vissel B. Inflammation&#x2010;sleep interface in brain disease: TNF, insulin, orexin. J Neuroinflammation. 2014;11:51. doi:10.1186/1742-2094-11-51</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-51</ArticleId><ArticleId IdType="pmc">PMC3994460</ArticleId><ArticleId IdType="pubmed">24655719</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark IA. Chronic cerebral aspects of long COVID, post&#x2010;stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic. Pharmacol Res Perspect. 2022;10(2):e00926. doi:10.1002/prp2.926</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.926</ArticleId><ArticleId IdType="pmc">PMC8850677</ArticleId><ArticleId IdType="pubmed">35174650</ArticleId></ArticleIdList></Reference><Reference><Citation>Moraes CA, Zaverucha&#x2010;do&#x2010;Valle C, Fleurance R, Sharshar T, Bozza FA, d'Avila JC. Neuroinflammation in sepsis: molecular pathways of microglia activation. Pharmaceuticals (Basel). 2021;14(5):416. doi:10.3390/ph14050416</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14050416</ArticleId><ArticleId IdType="pmc">PMC8147235</ArticleId><ArticleId IdType="pubmed">34062710</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;Casta&#xf1;eda A, Lu P, Geraghty AC, et al. Mild respiratory COVID can cause multi&#x2010;lineage neural cell and myelin dysregulation. Cell. 2022;185(14):2452&#x2010;2468.e16. doi:10.1016/j.cell.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao J, Frankland PW. COVID fog demystified. Cell. 2022;185(14):2391&#x2010;2393. doi:10.1016/j.cell.2022.06.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.020</ArticleId><ArticleId IdType="pmc">PMC9197953</ArticleId><ArticleId IdType="pubmed">35768007</ArticleId></ArticleIdList></Reference><Reference><Citation>Maillet I, Schnyder&#x2010;Candrian S, Couillin I, et al. Allergic lung inflammation is mediated by soluble tumor necrosis factor (TNF) and attenuated by dominant&#x2010;negative TNF biologics. Am J Respir Cell Mol Biol. 2011;45(4):731&#x2010;739. doi:10.1165/rcmb.2010-0512OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2010-0512OC</ArticleId><ArticleId IdType="pubmed">21297077</ArticleId></ArticleIdList></Reference><Reference><Citation>Iosif RE, Ekdahl CT, Ahlenius H, et al. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci. 2006;26(38):9703&#x2010;9712. doi:10.1523/jneurosci.2723-06.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.2723-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674454</ArticleId><ArticleId IdType="pubmed">16988041</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen CH, Tsai RY, Shih MS, et al. Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine&#x2010;tolerant rats. Anesth Analg. 2011;112(2):454&#x2010;459. doi:10.1213/ANE.0b013e3182025b15</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182025b15</ArticleId><ArticleId IdType="pubmed">21081778</ArticleId></ArticleIdList></Reference><Reference><Citation>Mursic VP, Wanner G, Reinhardt S, Wilske B, Busch U, Marget W. Formation and cultivation of Borrelia burgdorferi spheroplast&#x2010;L&#x2010;form variants. Infection. 1996;24(3):218&#x2010;226. doi:10.1007/bf01781096</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf01781096</ArticleId><ArticleId IdType="pubmed">8811359</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonks A. Lyme wars. BMJ. 2007;335(7626):910&#x2010;912. doi:10.1136/bmj.39363.530961.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39363.530961.AD</ArticleId><ArticleId IdType="pmc">PMC2048873</ArticleId><ArticleId IdType="pubmed">17974685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal LH, Hassett AL. Commentary: 'What's in a name? That which we call a rose by any other name would smell as sweet.' Shakespeare W. Romeo and Juliet, II, ii(47&#x2013;48). Int J Epidemiol. 2005;34(6):1345&#x2010;1347. doi:10.1093/ije/dyi180</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyi180</ArticleId><ArticleId IdType="pubmed">16143662</ArticleId></ArticleIdList></Reference><Reference><Citation>Radolf JD, Strle K, Lemieux JE, Strle F. Lyme disease in humans. Curr Issues Mol Biol. 2021;42:333&#x2010;384. doi:10.21775/cimb.042.333</Citation><ArticleIdList><ArticleId IdType="doi">10.21775/cimb.042.333</ArticleId><ArticleId IdType="pmc">PMC7946767</ArticleId><ArticleId IdType="pubmed">33303701</ArticleId></ArticleIdList></Reference><Reference><Citation>Lochhead RB, Strle K, Arvikar SL, Weis JJ, Steere AC. Lyme arthritis: linking infection, inflammation and autoimmunity. Nat Rev Rheumatol. 2021;17(8):449&#x2010;461. doi:10.1038/s41584-021-00648-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00648-5</ArticleId><ArticleId IdType="pmc">PMC9488587</ArticleId><ArticleId IdType="pubmed">34226730</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin JM, Yang T, Rebman AW, et al. Imaging glial activation in patients with post&#x2010;treatment Lyme disease symptoms: a pilot study using [(11)C]DPA&#x2010;713 PET. J Neuroinflammation. 2018;15(1):346. doi:10.1186/s12974-018-1381-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1381-4</ArticleId><ArticleId IdType="pmc">PMC6299943</ArticleId><ArticleId IdType="pubmed">30567544</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappata S, Levasseur M, Gunn RN, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology. 2000;55(7):1052&#x2010;1054.</Citation><ArticleIdList><ArticleId IdType="pubmed">11061271</ArticleId></ArticleIdList></Reference><Reference><Citation>Folkersma H, Boellaard R, Yaqub M, et al. Widespread and prolonged increase in (R)&#x2010;(11)C&#x2010;PK11195 binding after traumatic brain injury. J Nucl Med. 2011;52(8):1235&#x2010;1239. doi:10.2967/jnumed.110.084061</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.110.084061</ArticleId><ArticleId IdType="pubmed">21764792</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Fang C, Wang J, et al. Neuroinflammatory biomarkers in the brain, cerebrospinal fluid, and blood after ischemic stroke. Mol Neurobiol. 2023;60:5117&#x2010;5136. doi:10.1007/s12035-023-03399-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-023-03399-4</ArticleId><ArticleId IdType="pubmed">37258724</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel A, Radlinska BA, Paquette C, et al. The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging&#x2010;guided PET study with 11C&#x2010;PK11195 in acute subcortical stroke. J Nucl Med. 2010;51(9):1404&#x2010;1412. doi:10.2967/jnumed.110.076612</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.110.076612</ArticleId><ArticleId IdType="pubmed">20720039</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaechter JD, Hightower BG, Kim M, Loggia ML. A pilot [(11)C]PBR28 PET/MRI study of neuroinflammation and neurodegeneration in chronic stroke patients. Brain Behav Immun Health. 2021;17:100336. doi:10.1016/j.bbih.2021.100336</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100336</ArticleId><ArticleId IdType="pmc">PMC8474408</ArticleId><ArticleId IdType="pubmed">34589819</ArticleId></ArticleIdList></Reference><Reference><Citation>Candelario&#x2010;Jalil E, Dijkhuizen RM, Magnus T. Neuroinflammation, stroke, blood&#x2010;brain barrier dysfunction, and imaging modalities. Stroke. 2022;53(5):1473&#x2010;1486. doi:10.1161/strokeaha.122.036946</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.122.036946</ArticleId><ArticleId IdType="pmc">PMC9038693</ArticleId><ArticleId IdType="pubmed">35387495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralph SJ, Weissenberger A, Bonev V, et al. Phase I/II parallel double&#x2010;blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation. Expert Opin Investig Drugs. 2020;29:311&#x2010;326. doi:10.1080/13543784.2020.1709822</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2020.1709822</ArticleId><ArticleId IdType="pubmed">31899977</ArticleId></ArticleIdList></Reference><Reference><Citation>Faden AI, Wu J, Stoica BA, Loane DJ. Progressive inflammation&#x2010;mediated neurodegeneration after traumatic brain or spinal cord injury. Br J Pharmacol. 2016;173(4):681&#x2010;691. doi:10.1111/bph.13179</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13179</ArticleId><ArticleId IdType="pmc">PMC4742301</ArticleId><ArticleId IdType="pubmed">25939377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio CC, Lin JW, Chang MW, et al. Therapeutic evaluation of etanercept in a model of traumatic brain injury. J Neurochem. 2010;115(4):921&#x2010;929. doi:10.1111/j.1471-4159.2010.06969.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06969.x</ArticleId><ArticleId IdType="pubmed">20796174</ArticleId></ArticleIdList></Reference><Reference><Citation>Witcher KG, Bray CE, Chunchai T, et al. Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by microglia. J Neurosci. 2021;41(7):1597&#x2010;1616. doi:10.1523/jneurosci.2469-20.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.2469-20.2020</ArticleId><ArticleId IdType="pmc">PMC7896020</ArticleId><ArticleId IdType="pubmed">33452227</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathbone AT, Tharmaradinam S, Jiang S, Rathbone MP, Kumbhare DA. A review of the neuro&#x2010; and systemic inflammatory responses in post concussion symptoms: introduction of the "post&#x2010;inflammatory brain syndrome" PIBS. Brain Behav Immun. 2015;46:1&#x2010;16. doi:10.1016/j.bbi.2015.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.02.009</ArticleId><ArticleId IdType="pubmed">25736063</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried E, Balla U, Catalogna M, et al. Persistent post&#x2010;concussive syndrome in children after mild traumatic brain injury is prevalent and vastly underdiagnosed. Sci Rep. 2022;12(1):4364. doi:10.1038/s41598-022-08302-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08302-0</ArticleId><ArticleId IdType="pmc">PMC8921281</ArticleId><ArticleId IdType="pubmed">35288616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganz PA, Bower JE, Kwan L, et al. Does tumor necrosis factor&#x2010;alpha (TNF&#x2010;&#x3b1;) play a role in post&#x2010;chemotherapy cerebral dysfunction? Brain Behav Immun. 2013;30 Suppl(Suppl):S99&#x2010;S108. doi:10.1016/j.bbi.2012.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2012.07.015</ArticleId><ArticleId IdType="pmc">PMC3522786</ArticleId><ArticleId IdType="pubmed">22884417</ArticleId></ArticleIdList></Reference><Reference><Citation>Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999;85(3):640&#x2010;650. doi:10.1002/(sici)1097-0142(19990201)85:3&lt;640::aid-cncr14&gt;3.0.co;2-g</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-0142(19990201)85:3&lt;640::aid-cncr14&gt;3.0.co;2-g</ArticleId><ArticleId IdType="pubmed">10091737</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman DH, Dy CJ, Castellon SA, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant&#x2010;treated breast cancer survivors 5&#x2010;10&#x2009;years after chemotherapy. Breast Cancer Res Treat. 2007;103(3):303&#x2010;311. doi:10.1007/s10549-006-9380-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10549-006-9380-z</ArticleId><ArticleId IdType="pubmed">17009108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson EM, Monje M. Microglia in cancer therapy&#x2010;related cognitive impairment. Trends Neurosci. 2021;44(6):441&#x2010;451. doi:10.1016/j.tins.2021.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2021.02.003</ArticleId><ArticleId IdType="pmc">PMC8593823</ArticleId><ArticleId IdType="pubmed">33674135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahles TA, Saykin AJ, Noll WW, et al. The relationship of APOE genotype to neuropsychological performance in long&#x2010;term cancer survivors treated with standard dose chemotherapy. Psychooncology. 2003;12(6):612&#x2010;619. doi:10.1002/pon.742</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.742</ArticleId><ArticleId IdType="pubmed">12923801</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale SC, Gao L, Mikacenic C, et al. APO&#x3b5;4 is associated with enhanced in vivo innate immune responses in human subjects. J Allergy Clin Immunol. 2014;134(1):127&#x2010;134. doi:10.1016/j.jaci.2014.01.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.01.032</ArticleId><ArticleId IdType="pmc">PMC4125509</ArticleId><ArticleId IdType="pubmed">24655576</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Huang Y, Duan M, Yang Q, Ren B, Tang F. Microglia as therapeutic target for radiation&#x2010;induced brain injury. Int J Mol Sci. 2022;23(15):8286. doi:10.3390/ijms23158286</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158286</ArticleId><ArticleId IdType="pmc">PMC9368164</ArticleId><ArticleId IdType="pubmed">35955439</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenrow KA, Brown SL, Lapanowski K, Naei H, Kolozsvary A, Kim JH. Selective inhibition of microglia&#x2010;mediated neuroinflammation mitigates radiation&#x2010;induced cognitive impairment. Radiat Res. 2013;179(5):549&#x2010;556. doi:10.1667/rr3026.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1667/rr3026.1</ArticleId><ArticleId IdType="pmc">PMC3673739</ArticleId><ArticleId IdType="pubmed">23560629</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaeb S, Dammann O. Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol. 2009;24(9):1119&#x2010;1126. doi:10.1177/0883073809338066</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073809338066</ArticleId><ArticleId IdType="pmc">PMC3695470</ArticleId><ArticleId IdType="pubmed">19605775</ArticleId></ArticleIdList></Reference><Reference><Citation>Aden U, Favrais G, Plaisant F, et al. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro&#x2212;/anti&#x2010;inflammatory imbalance: key role of TNF pathway and protection by etanercept. Brain Behav Immun. 2010;24(5):747&#x2010;758.</Citation><ArticleIdList><ArticleId IdType="pubmed">19861157</ArticleId></ArticleIdList></Reference><Reference><Citation>Galinsky R, Dhillon SK, Dean JM, et al. Tumor necrosis factor inhibition attenuates white matter gliosis after systemic inflammation in preterm fetal sheep. J Neuroinflammation. 2020;17(1):92. doi:10.1186/s12974-020-01769-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01769-6</ArticleId><ArticleId IdType="pmc">PMC7087378</ArticleId><ArticleId IdType="pubmed">32293473</ArticleId></ArticleIdList></Reference><Reference><Citation>Back SA, Riddle A, Dean J, Hohimer AR. The instrumented fetal sheep as a model of cerebral white matter injury in the premature infant. Neurotherapeutics. 2012;9(2):359&#x2010;370. doi:10.1007/s13311-012-0108-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-012-0108-y</ArticleId><ArticleId IdType="pmc">PMC3337024</ArticleId><ArticleId IdType="pubmed">22399133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lear CA, Lear BA, Davidson JO, et al. Tumour necrosis factor blockade after asphyxia in foetal sheep ameliorates cystic white matter injury. Brain. 2022;146:1453&#x2010;1466. doi:10.1093/brain/awac331</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac331</ArticleId><ArticleId IdType="pmc">PMC10115165</ArticleId><ArticleId IdType="pubmed">36087304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lear BA, Lear CA, Dhillon SK, Davidson JO, Bennet L, Gunn AJ. Is late prevention of cerebral palsy in extremely preterm infants plausible? Dev Neurosci. 2022;44(4&#x2013;5):177&#x2010;185. doi:10.1159/000521618</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000521618</ArticleId><ArticleId IdType="pubmed">34937030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahluwalia B, Wesley B, Adeyiga O, Smith DM, Da&#x2010;Silva A, Rajguru S. Alcohol modulates cytokine secretion and synthesis in human fetus: an in vivo and in vitro study. Alcohol. 2000;21(3):207&#x2010;213. doi:10.1016/s0741-8329(00)00076-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0741-8329(00)00076-8</ArticleId><ArticleId IdType="pubmed">11091023</ArticleId></ArticleIdList></Reference><Reference><Citation>Boschen KE, Ruggiero MJ, Klintsova AY. Neonatal binge alcohol exposure increases microglial activation in the developing rat hippocampus. Neuroscience. 2016;324:355&#x2010;366. doi:10.1016/j.neuroscience.2016.03.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.03.033</ArticleId><ArticleId IdType="pmc">PMC4838517</ArticleId><ArticleId IdType="pubmed">26996510</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore M, Petrella C, Coriale G, et al. Markers of neuroinflammation in the serum of prepubertal children with fetal alcohol spectrum disorders. CNS Neurol Disord Drug Targets. 2022;21(9):854&#x2010;868. doi:10.2174/1871527320666211201154839</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527320666211201154839</ArticleId><ArticleId IdType="pubmed">34852752</ArticleId></ArticleIdList></Reference><Reference><Citation>Chastain LG, Franklin T, Gangisetty O, et al. Early life alcohol exposure primes hypothalamic microglia to later&#x2010;life hypersensitivity to immune stress: possible epigenetic mechanism. Neuropsychopharmacology. 2019;44(9):1579&#x2010;1588. doi:10.1038/s41386-019-0326-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-019-0326-7</ArticleId><ArticleId IdType="pmc">PMC6785096</ArticleId><ArticleId IdType="pubmed">30737481</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantacorps L, Montagud&#x2010;Romero S, Valverde O. Curcumin treatment attenuates alcohol&#x2010;induced alterations in a mouse model of foetal alcohol spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109899. doi:10.1016/j.pnpbp.2020.109899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.109899</ArticleId><ArticleId IdType="pubmed">32109509</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual M, Fern&#xe1;ndez&#x2010;Lizarbe S, Guerri C. Role of TLR4 in ethanol effects on innate and adaptive immune responses in peritoneal macrophages. Immunol Cell Biol. 2011;89(6):716&#x2010;727. doi:10.1038/icb.2010.163</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2010.163</ArticleId><ArticleId IdType="pubmed">21221123</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro&#x2010;inflammatory biomarkers. Br J Pharmacol. 2013;169(8):1672&#x2010;1692. doi:10.1111/bph.12131</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12131</ArticleId><ArticleId IdType="pmc">PMC3753829</ArticleId><ArticleId IdType="pubmed">23425071</ArticleId></ArticleIdList></Reference><Reference><Citation>Eidson LN, Inoue K, Young LJ, Tansey MG, Murphy AZ. Toll&#x2010;like receptor 4 mediates morphine&#x2010;induced Neuroinflammation and tolerance via soluble tumor necrosis factor signaling. Neuropsychopharmacology. 2017;42(3):661&#x2010;670. doi:10.1038/npp.2016.131</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2016.131</ArticleId><ArticleId IdType="pmc">PMC5240168</ArticleId><ArticleId IdType="pubmed">27461080</ArticleId></ArticleIdList></Reference><Reference><Citation>Chastre A, B&#xe9;langer M, Beauchesne E, Nguyen BN, Desjardins P, Butterworth RF. Inflammatory cascades driven by tumor necrosis factor&#x2010;alpha play a major role in the progression of acute liver failure and its neurological complications. PLoS One. 2012;7(11):e49670. doi:10.1371/journal.pone.0049670</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049670</ArticleId><ArticleId IdType="pmc">PMC3499491</ArticleId><ArticleId IdType="pubmed">23166746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignatowski TA, Noble BK, Wright JR, Gorfien JL, Spengler RN. TNFalpha: a neuromodulator in the central nervous system. Adv Exp Med Biol. 1996;402:219&#x2010;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">8787663</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson GJ, Ohashi Y, Reynolds GP, Pratt JA, Morris BJ. Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP&#x2010;treated rats and human schizophrenic subjects: influence of antipsychotic drugs. J Psychopharmacol. 2006;20(5):636&#x2010;642. doi:10.1177/0269881106062025</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881106062025</ArticleId><ArticleId IdType="pubmed">16478754</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Poletti S, Benedetti F. Post&#x2010;COVID&#x2010;19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681&#x2010;702. doi:10.1007/s40263-022-00931-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6&#x2010;month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID&#x2010;19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2010;427. doi:10.1016/s2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai W, Mueller C, Li YJ, Shen WD, Stewart R. Post stroke depression and risk of stroke recurrence and mortality: a systematic review and meta&#x2010;analysis. Ageing Res Rev. 2019;50:102&#x2010;109. doi:10.1016/j.arr.2019.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2019.01.013</ArticleId><ArticleId IdType="pubmed">30711712</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry DC, Sturm VE, Peterson MJ, et al. Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta&#x2010;analysis. J Neurosurg. 2016;124(2):511&#x2010;526. doi:10.3171/2015.2.Jns14503</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2015.2.Jns14503</ArticleId><ArticleId IdType="pmc">PMC4751029</ArticleId><ArticleId IdType="pubmed">26315003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloomfield PS, Selvaraj S, Veronese M, et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study. Am J Psychiatry. 2016;173(1):44&#x2010;52. doi:10.1176/appi.ajp.2015.14101358</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2015.14101358</ArticleId><ArticleId IdType="pmc">PMC4821370</ArticleId><ArticleId IdType="pubmed">26472628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoseth EZ, Ueland T, Dieset I, et al. A study of TNF pathway activation in schizophrenia and bipolar disorder in plasma and brain tissue. Schizophr Bull. 2017;43(4):881&#x2010;890. doi:10.1093/schbul/sbw183</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbw183</ArticleId><ArticleId IdType="pmc">PMC5515106</ArticleId><ArticleId IdType="pubmed">28049760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansur RB, Subramaniapillai M, Lee Y, et al. Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression. Psychoneuroendocrinology. 2020;120:104779. doi:10.1016/j.psyneuen.2020.104779</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2020.104779</ArticleId><ArticleId IdType="pubmed">32603956</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark IA, Alleva LM, Vissel B. TNF and leptin tell essentially the same story in Alzheimer's disease. J Alzheimers Dis. 2011;26(2):201&#x2010;205. doi:10.3233/jad-2011-110266</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-2011-110266</ArticleId><ArticleId IdType="pubmed">21593567</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Hamdani N, Kapczinski F, et al. Effectiveness and tolerance of anti&#x2010;inflammatory drugs' add&#x2010;on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand. 2014;129(3):163&#x2010;179. doi:10.1111/acps.12211</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acps.12211</ArticleId><ArticleId IdType="pubmed">24215721</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, He Y, Sun Z, et al. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflammation. 2022;19(1):132. doi:10.1186/s12974-022-02492-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02492-0</ArticleId><ArticleId IdType="pmc">PMC9168645</ArticleId><ArticleId IdType="pubmed">35668399</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Dai J, Tang L, et al. Neuroimmune transcriptome changes in patient brains of psychiatric and neurological disorders. Mol Psychiatry. 2022;28:710&#x2010;721. doi:10.1038/s41380-022-01854-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01854-7</ArticleId><ArticleId IdType="pmc">PMC9911365</ArticleId><ArticleId IdType="pubmed">36424395</ArticleId></ArticleIdList></Reference><Reference><Citation>Keilp JG, Corbera K, Slavov I, Taylor MJ, Sackeim HA, Fallon BA. WAIS&#x2010;III and WMS&#x2010;III performance in chronic Lyme disease. J Int Neuropsychol Soc. 2006;12(1):119&#x2010;129. doi:10.1017/s1355617706060231</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1355617706060231</ArticleId><ArticleId IdType="pubmed">16433951</ArticleId></ArticleIdList></Reference><Reference><Citation>Bransfield RC, Aidlen DM, Cook MJ, Javia S. A clinical diagnostic system for late&#x2010;stage neuropsychiatric Lyme Borreliosis based upon an analysis of 100 patients. Healthcare (Basel, Switzerland). 2020;8(1):13. doi:10.3390/healthcare8010013</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8010013</ArticleId><ArticleId IdType="pmc">PMC7151210</ArticleId><ArticleId IdType="pubmed">31935905</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak CB, Scheeler VM, Aucott JN. Lyme disease in the era of COVID&#x2010;19: a delayed diagnosis and risk for complications. Case Rep Infect Dis. 2021;2021:6699536. doi:10.1155/2021/6699536</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6699536</ArticleId><ArticleId IdType="pmc">PMC7883710</ArticleId><ArticleId IdType="pubmed">33628543</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank MG, Fleshner M, Maier SF. Exploring the immunogenic properties of SARS&#x2010;CoV&#x2010;2 structural proteins: PAMP:TLR signaling in the mediation of the neuroinflammatory and neurologic sequelae of COVID&#x2010;19. Brain Behav Immun. 2023;111:259&#x2010;269. doi:10.1016/j.bbi.2023.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.04.009</ArticleId><ArticleId IdType="pmc">PMC10132835</ArticleId><ArticleId IdType="pubmed">37116592</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira AL, Gama CS, Rocha NP, Teixeira MM. Revisiting the role of eotaxin&#x2010;1/CCL11 in psychiatric disorders. Front Psych. 2018;9:241. doi:10.3389/fpsyt.2018.00241</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00241</ArticleId><ArticleId IdType="pmc">PMC6010544</ArticleId><ArticleId IdType="pubmed">29962972</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLeo JA, Rutkowski MD, Stalder AK, Campbell IL. Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model. Neuroreport. 2000;11(3):599&#x2010;602. doi:10.1097/00001756-200002280-00033</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200002280-00033</ArticleId><ArticleId IdType="pubmed">10718321</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick EL, Britschgi&#x2010;Davoodifar S. Perispinal TNF&#x2010;alpha inhibition for discogenic pain. Swiss Med Wkly. 2003;133(11&#x2013;12):170&#x2010;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">12715286</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanga FY, Nutile&#x2010;McMenemy N, DeLeo JA. The CNS role of toll&#x2010;like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA. 2005;102(16):5856&#x2010;5861. doi:10.1073/pnas.0501634102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501634102</ArticleId><ArticleId IdType="pmc">PMC556308</ArticleId><ArticleId IdType="pubmed">15809417</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan MM, Hutchinson M, Watkins LR, Yin H. Toll&#x2010;like receptor 4 in CNS pathologies. J Neurochem. 2010;114(1):13&#x2010;27. doi:10.1111/j.1471-4159.2010.06736.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06736.x</ArticleId><ArticleId IdType="pmc">PMC2909662</ArticleId><ArticleId IdType="pubmed">20402965</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung L, Cahill CM. TNF&#x2010;alpha and neuropathic pain&#x2010;&#x2010;a review. J Neuroinflammation. 2010;7:27. doi:10.1186/1742-2094-7-27</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-27</ArticleId><ArticleId IdType="pmc">PMC2861665</ArticleId><ArticleId IdType="pubmed">20398373</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerard E, Spengler RN, Bonoiu AC, et al. Chronic constriction injury&#x2010;induced nociception is relieved by nanomedicine&#x2010;mediated decrease of rat hippocampal tumor necrosis factor. Pain. 2015;156(7):1320&#x2010;1333. doi:10.1097/j.pain.0000000000000181</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000181</ArticleId><ArticleId IdType="pmc">PMC4474806</ArticleId><ArticleId IdType="pubmed">25851457</ArticleId></ArticleIdList></Reference><Reference><Citation>LaMacchia ZM, Spengler RN, Jaffari M, et al. Perispinal injection of a TNF blocker directed to the brain of rats alleviates the sensory and affective components of chronic constriction injury&#x2010;induced neuropathic pain. Brain Behav Immun. 2019;82:93&#x2010;105. doi:10.1016/j.bbi.2019.07.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.07.036</ArticleId><ArticleId IdType="pubmed">31376497</ArticleId></ArticleIdList></Reference><Reference><Citation>Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci. 2009;10(1):23&#x2010;36. doi:10.1038/nrn2533</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2533</ArticleId><ArticleId IdType="pmc">PMC2752436</ArticleId><ArticleId IdType="pubmed">19096368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledeboer A, Sloane EM, Milligan ED, et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain. 2005;115(1&#x2013;2):71&#x2010;83. doi:10.1016/j.pain.2005.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2005.02.009</ArticleId><ArticleId IdType="pubmed">15836971</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker WC. Pain pathoetiology after TBI: neural and nonneural mechanisms. J Head Trauma Rehabil. 2004;19(1):72&#x2010;81. doi:10.1097/00001199-200401000-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001199-200401000-00007</ArticleId><ArticleId IdType="pubmed">14732832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostojic K, Paget SP, Morrow AM. Management of pain in children and adolescents with cerebral palsy: a systematic review. Dev Med Child Neurol. 2019;61(3):315&#x2010;321. doi:10.1111/dmcn.14088</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dmcn.14088</ArticleId><ArticleId IdType="pubmed">30378122</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor S, Milligan ED. Lifelong impacts of moderate prenatal alcohol exposure on neuroimmune function. Front Immunol. 2018;9:1107. doi:10.3389/fimmu.2018.01107</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01107</ArticleId><ArticleId IdType="pmc">PMC5992426</ArticleId><ArticleId IdType="pubmed">29910801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazamel M, Pischik E, Desnick RJ. Pain in acute hepatic porphyrias: updates on pathophysiology and management. Front Neurol. 2022;13:1004125. doi:10.3389/fneur.2022.1004125</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1004125</ArticleId><ArticleId IdType="pmc">PMC9719963</ArticleId><ArticleId IdType="pubmed">36479055</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcelon EE, Cho WH, Jun SB, Lee SJ. Brain microglial activation in chronic pain&#x2010;associated affective disorder. Front Neurosci. 2019;13:213. doi:10.3389/fnins.2019.00213</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00213</ArticleId><ArticleId IdType="pmc">PMC6436078</ArticleId><ArticleId IdType="pubmed">30949019</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchand F, Tsantoulas C, Singh D, et al. Effects of Etanercept and minocycline in a rat model of spinal cord injury. Eur J Pain. 2009;13(7):673&#x2010;681. doi:10.1016/j.ejpain.2008.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpain.2008.08.001</ArticleId><ArticleId IdType="pubmed">18849175</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J, Li L, Xie J, Wu Y, Wu X, Li W. Toll&#x2010;like receptor&#x2010;4 pathway is required for the pathogenesis of human chronic endometritis. Exp Ther Med. 2014;8(6):1896&#x2010;1900. doi:10.3892/etm.2014.1990</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2014.1990</ArticleId><ArticleId IdType="pmc">PMC4217777</ArticleId><ArticleId IdType="pubmed">25371751</ArticleId></ArticleIdList></Reference><Reference><Citation>Barra F, Ferro Desideri L, Ferrero S. Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis. Br J Pharmacol. 2018;175(17):3626&#x2010;3627. doi:10.1111/bph.14391</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14391</ArticleId><ArticleId IdType="pmc">PMC6086976</ArticleId><ArticleId IdType="pubmed">29984446</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashir ST, Redden CR, Raj K, et al. Endometriosis leads to central nervous system&#x2010;wide glial activation in a mouse model of endometriosis. J Neuroinflammation. 2023;20(1):59. doi:10.1186/s12974-023-02713-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-023-02713-0</ArticleId><ArticleId IdType="pmc">PMC9987089</ArticleId><ArticleId IdType="pubmed">36879305</ArticleId></ArticleIdList></Reference><Reference><Citation>Morotti M, Vincent K, Becker CM. Mechanisms of pain in endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017;209:8&#x2010;13. doi:10.1016/j.ejogrb.2016.07.497</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2016.07.497</ArticleId><ArticleId IdType="pubmed">27522645</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapero C, Mart&#xed;n&#x2010;Satu&#xe9; M. Purinergic signaling in endometriosis&#x2010;associated pain. Int J Mol Sci. 2020;21(22):8512. doi:10.3390/ijms21228512</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228512</ArticleId><ArticleId IdType="pmc">PMC7697899</ArticleId><ArticleId IdType="pubmed">33198179</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiba K. Discovery of fingolimod based on the chemical modification of a natural product from the fungus, Isaria sinclairii . J Antibiot. 2020;73(10):666&#x2010;678. doi:10.1038/s41429-020-0351-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41429-020-0351-0</ArticleId><ArticleId IdType="pubmed">32681100</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Sui R, Zhang L. Fingolimod protects against cerebral ischemia reperfusion injury in rats by reducing inflammatory cytokines and inhibiting the activation of p38 MAPK and NF&#x2010;&#x3ba;B signaling pathways. Neurosci Lett. 2022;771:136413. doi:10.1016/j.neulet.2021.136413</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2021.136413</ArticleId><ArticleId IdType="pubmed">34942319</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreras I, Jung Y, Lopez&#x2010;Benitez J, Tognoni CM, Dedeoglu A. Fingolimod mitigates memory loss in a mouse model of Gulf War illness amid decreasing the activation of microglia, protein kinase R, and NF&#x3ba;B. Neurotoxicology. 2023;96:197&#x2010;206. doi:10.1016/j.neuro.2023.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2023.05.006</ArticleId><ArticleId IdType="pmc">PMC10334821</ArticleId><ArticleId IdType="pubmed">37160207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Cho JH, Yeo J, et al. The pharmacology study of a new recombinant TNF receptor&#x2010;hyFc fusion protein. Biologicals. 2013;41(2):77&#x2010;83. doi:10.1016/j.biologicals.2012.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biologicals.2012.09.001</ArticleId><ArticleId IdType="pubmed">23190454</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott MJ, Maini RN, Feldmann M, et al. Randomised double&#x2010;blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994;344(8930):1105&#x2010;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">7934491</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse DD, Pereira FC, Stolyarova A, Barakat DJ, Bunge MB. Inhibition of tumour necrosis factor&#x2010;alpha by antisense targeting produces immunophenotypical and morphological changes in injury&#x2010;activated microglia and macrophages. Eur J Neurosci. 2004;20(12):3387&#x2010;3396. doi:10.1111/j.1460-9568.2004.03799.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2004.03799.x</ArticleId><ArticleId IdType="pubmed">15610171</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark IA. Editorial: an unsound AAN practice advisory on poststroke etanercept. Expert Rev Neurother. 2017;17(3):215&#x2010;217. doi:10.1080/14737175.2017.1282315</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2017.1282315</ArticleId><ArticleId IdType="pubmed">28081625</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>